Design Therapeutics, Inc. Intrinsic Value

DSGN

Design Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Design Therapeutics today, so there is nothing to project yet.

Peers

Pharmaceutical Preparations · Pick stocks to compare with DSGN

CompareIntrinsic value

TENXTenax Therapeutics Inc.

$1.81-1.63%10

LEXXLexaria Bioscience Corp.

$4.07+0.99%10

PRPHProPhase Labs Inc.

$0.01-42.00%0

CBIOCrescent Biopharma, Inc.

$13.42+2.76%50

OGNOrganon & Co.

$13.83-0.14%28

PTCTPTC Therapeutics, Inc.

$68.97+1.25%65

BCYCBicycle Therapeutics PLC

$3.72+1.36%40

BMYBristol-Myers Squibb Company

$64.20+4.04%61

Held by ETFs

DSGN is in 22 US ETFs. The largest of them, with DSGN's weight in each:

Spot a number that looks wrong? Check it in DSGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DSGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.